Lexicon Pharmaceuticals
LXRX
#6659
Rank
NZ$1.18 B
Marketcap
NZ$2.79
Share price
-3.05%
Change (1 day)
251.67%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): NZ-$0.34

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.33. In 2024 the company made an earnings per share (EPS) of NZ-$1.12 an increase over its 2023 EPS that were of NZ-$1.40.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.34-70.14%
2024NZ-$1.12-20%
2023NZ-$1.4031.15%
2022NZ-$1.07-0%
2021NZ-$1.0710.91%
2020NZ-$0.97-145.08%
2019NZ$2.14-206.09%
2018NZ-$2.02-5.74%
2017NZ-$2.14-10.95%
2016NZ-$2.412640%
2015NZ-$0.08781-96.34%
2014NZ-$2.40-2.53%
2013NZ-$2.46-9.09%
2012NZ-$2.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$31.21-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.62-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$75.73-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$10.26 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$11.06-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.88 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.32 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$3.20-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$134.72 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA